Seminars in Oncology
Volume 36, Issue 5 , Pages 478-488, October 2009

The Adolescence of Young Adult Oncology

  • Karen Albritton

      Affiliations

    • Dana-Farber Cancer Institute, Harvard University, Boston, MA
  • ,
  • Ronald Barr

      Affiliations

    • Departments of Pediatrics, Pathology, and Medicine, McMaster University, Hamilton, Ontario, Canada
  • ,
  • Archie Bleyer

      Affiliations

    • Department of Radiation Medicine, Oregon Health and Science University, Portland, OR; St. Charles Medical Center, Bend, OR
    • Corresponding Author InformationAddress correspondence to Archie Bleyer, MD, St. Charles Medical Center, 2500 NE Neff Rd, Bend, OR 97701

The clinical care of young adults with cancer, and related research, was a novel focus of oncology a decade ago, but 10 years of data on patients' needs and outcome disparities, well-reviewed in the articles of this special issue and its predecessor (June 2009), prove the merit of this subspecialty. The field, emerging from its childhood and entering adolescence, must continue to look to the future to solidify its worth. In this concluding article we examine important themes that must receive attention for the discipline to develop and flourish. We must overcome the challenges inherent in serving a population that is difficult to define, and which crosses traditional boundaries and disciplines. The field must strengthen its research in clinical trials and comparative outcomes, and must articulate the key competencies that distinguish a practitioner of young adult oncology (both to define clinical programs and educational curricula). Key opportunities are collaborations with leaders in oncofertility, developmental psychology, and transitional care, and with patient advocates. We must garner support from federal entities, as well as philanthropic agencies and accrediting bodies. With strategic effort, the field of young adult oncology will mature and grow wise.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the Aflac Foundation.

PII: S0093-7754(09)00142-0

doi:10.1053/j.seminoncol.2009.07.007

Seminars in Oncology
Volume 36, Issue 5 , Pages 478-488, October 2009